Crosstalk between triple negative breast cancer and microenvironment.
Loading...
Issue Date
3/31/2023
Authors
Smrekar, Karly*
Belyakov, Artem*
Jin, Kideok
Degree
Advisor
Committee Members
Journal Title
Journal ISSN
Volume Title
Abstract
Although many advances have been made in the treatment of breast cancer, for the triple negative breast cancer (TNBC) these therapies have not significantly increased overall survival. Tumor microenvironment (TME) plays an essential role to develop and control TNBC progression. Many preclinical and clinical studies are ongoing to treat patients with TNBC disease, but the effective therapies are currently not available. Here, we have reviewed recent progress in understanding of TNBC and advance in defining mechanisms of TNBC therapies and potential therapeutic strategies to overcome TNBC.
Citation
Smrekar K, Belyakov A, Jin K. Crosstalk between triple negative breast cancer and microenvironment. Oncotarget. 2023 Mar 31;14:284-293. doi: 10.18632/oncotarget.28397. PMID: 36999995; PMCID: PMC10064880.
ACPHS Research Commons URI
Description
Click on the Resource Link to access the article (may not be free).